These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 216823)

  • 41. Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037).
    Sonntag RW; Brunner KW; Batz K; Ryssel HJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):429-31. PubMed ID: 50125
    [No Abstract]   [Full Text] [Related]  

  • 42. [Which chemotherapy for diffuse forms of small-cell cancers?].
    Pujol JL; Quantin X; Carestia L; Guyot V; Khial F
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S149-55. PubMed ID: 10088297
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapy of small-cell bronchial carcinoma].
    Bodemann HH; Arnold H; Wannenmacher M; Kraft A
    Dtsch Med Wochenschr; 1984 Jun; 109(23):913-5. PubMed ID: 6086263
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study].
    Kokron O; Micksche M; Titscher R; Wrba H
    Onkologie; 1982 Apr; 5(2):56-9. PubMed ID: 6285241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy of inoperable bronchogenic carcinoma.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 47. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung.
    Vincent RG; Lane WW; Raza S; Madajewicz S
    Cancer Treat Rep; 1982 Jan; 66(1):197-8. PubMed ID: 6975658
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
    [No Abstract]   [Full Text] [Related]  

  • 49. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

  • 50. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 51. [Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
    Kanda T; Oka M; Hara K; Koteda T; Ishizaki T; Ikebe A; Nakano M; Iwasaki H; Tsutsumi T; Okuno K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):12-8. PubMed ID: 3009666
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of small cell bronchogenic carcinoma with VM-26.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):2011-3. PubMed ID: 230897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
    Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
    Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chemotherapy of bronchopulmonary cancer. Trial of the BACON protocol].
    Adenis L; Restellini J; Caty A
    LARC Med; 1981 Nov; 1(2):50-1. PubMed ID: 6188012
    [No Abstract]   [Full Text] [Related]  

  • 55. cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.
    Dombernowsky P; Sörenson S; Aisner J; Hansen HH
    Cancer Treat Rep; 1979 Apr; 63(4):543-5. PubMed ID: 221119
    [No Abstract]   [Full Text] [Related]  

  • 56. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Some thoughts on surgical adjuvant studies in lung cancer.
    Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 60. Prognostic factors in patients with small-cell carcinoma of the lung.
    Chasen MR; Falkson G; van der Merwe CA; Dreyer RJ; Terblanche AP
    S Afr Med J; 1986 Dec; 70(13):812-4. PubMed ID: 3026057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.